PIGQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.611600E-01
Normal-vs-Stage2
9.077400E-01
Normal-vs-Stage3
1.709390E-01
Normal-vs-Stage4
4.328400E-01
Stage1-vs-Stage2
3.093600E-01
Stage1-vs-Stage3
1.231010E-01
Stage1-vs-Stage4
3.679800E-01
Stage2-vs-Stage3
9.472500E-02
Stage2-vs-Stage4
6.734800E-01
Stage3-vs-Stage4
2.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.423200E-01
Normal-vs-AfricanAmerican
6.246000E-01
Normal-vs-Asian
3.019200E-01
Caucasian-vs-AfricanAmerican
5.450400E-01
Caucasian-vs-Asian
6.554000E-02
AfricanAmerican-vs-Asian
7.262200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.872800E-01
Normal-vs-Female
9.407600E-01
Male-vs-Female
7.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.960000E-01
Normal-vs-Age(41-60Yrs)
8.359400E-01
Normal-vs-Age(61-80Yrs)
9.720400E-01
Normal-vs-Age(81-100Yrs)
8.288800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.737800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.286400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.765000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.004200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.496800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.591000E-01
Normal-vs-Daily Drinker
5.436800E-01
Normal-vs-Weekly Drinker
7.331200E-01
Normal-vs-Occasional Drinker
9.198400E-01
Normal-vs-Social Drinker
9.546000E-01
Non Drinker-vs-Daily Drinker
1.128970E-01
Non Drinker-vs-Weekly Drinker
4.427800E-01
Non Drinker-vs-Occasional Drinker
7.727000E-01
Non Drinker-vs-Social Drinker
9.548800E-01
Daily Drinker-vs-Weekly Drinker
5.584800E-01
Daily Drinker-vs-Occasional Drinker
4.497400E-01
Daily Drinker-vs-Social Drinker
2.180200E-01
Weekly Drinker-vs-Occasional Drinker
8.217600E-01
Weekly Drinker-vs-Social Drinker
5.174800E-01
Occasional Drinker-vs-Social Drinker
7.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.806200E-01
Normal-vs-Grade 2
2.837200E-01
Normal-vs-Grade 3
1.921590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.246400E-01
Grade 1-vs-Grade 3
8.288600E-01
Grade 1-vs-Grade 4
4.806200E-01
Grade 2-vs-Grade 3
5.901800E-01
Grade 2-vs-Grade 4
2.837200E-01
Grade 3-vs-Grade 4
1.921590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.290800E-01
Normal-vs-NonDiabetic
8.374600E-01
Diabetic-vs-NonDiabetic
3.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.132600E-01
Normal-vs-NoPancreatitis
9.706200E-01
Pancreatitis-vs-NoPancreatitis
6.439000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.374400E-01
Normal-vs-N1
7.856800E-01
N0-vs-N1
1.492230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.888000E-01
Normal-vs-TP53-NonMutant
7.721800E-01
TP53-Mutant-vs-TP53-NonMutant
1.480790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
